Randomized double-blinding controlled multicenter trial of Novaferon for Chronic hepatitis B.
Phase of Trial: Phase II
Latest Information Update: 21 May 2012
At a glance
- Drugs Interferon alpha-2b; Novaferon
- Indications Hepatitis B
- Focus Registrational; Therapeutic Use
- 21 May 2012 Planned End Date changed from 1 Jan 2011 to 31 Mar 2011 as reported by Chinese Clinical Trial Register record.
- 01 Oct 2010 New trial record